Follow
Laxminarayan Rawat
Laxminarayan Rawat
Postdoctoral Research Fellow, Harvard Medical School
Verified email at childrens.harvard.edu - Homepage
Title
Cited by
Cited by
Year
Piperlongumine induces ROS mediated cell death and synergizes paclitaxel in human intestinal cancer cells
L Rawat, H Hegde, SL Hoti, V Nayak
Biomedicine & Pharmacotherapy 128, 110243, 2020
582020
Ursolic acid disturbs ROS homeostasis and regulates survival-associated gene expression to induce apoptosis in intestinal cancer cells
L Rawat, V Nayak
Toxicology Research 10 (3), 369-375, 2021
132021
Piperlongumine induces ROS mediated apoptosis by transcriptional regulation of SMAD4/P21/P53 genes and synergizes with doxorubicin in osteosarcoma cells
L Rawat, V Nayak
Chemico-Biological Interactions 354, 109832, 2022
62022
A novel combination therapy with Cabozantinib and Honokiol effectively inhibits c-Met-Nrf2-induced renal tumor growth through increased oxidative stress
L Rawat, M Balan, Y Sasamoto, A Sabarwal, S Pal
Redox biology 68, 102945, 2023
22023
c-Met/AXL crosstalk in mediating therapeutic resistance in renal cell carcinoma
A Sabarwal, L Rawat, J Wedel, M Balan, GSM Lee, TK Choueiri, S Pal
Cancer Research 84 (6_Supplement), 4555-4555, 2024
2024
Targeting AXL can effectively inhibit c-Met-induced therapeutic resistance in renal cancer
A Sabarwal, L Rawat, J Wedel, Y Sasamoto, S Signoretti, TK Choueiri, ...
Cancer Research 83 (7_Supplement), 3866-3866, 2023
2023
A Study on Anticancer Potential of Piperlongumine and Ursolic Acid in Human Cancer Cell Lines invitro
L RAWAT
Pilani, 0
The system can't perform the operation now. Try again later.
Articles 1–7